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In preparing the main results paper from this trial, we
have noticed an important error in the study protocol
paper[1]. In the paragraph headed 'Outcome measures
and sample size calculations', the current text "A second-
ary outcome measure is smoking prevalence among the
entire year group." is incorrect, since smoking prevalence
among the entire year group is one of two primary out-
comes, rather than a secondary outcome. The equal status
of the two primary outcomes was agreed at a meeting of
the Trial Steering Committee on the 21st January 2005,
where the analysis plan was finalised prior to completion
of trial data collection. As indicated in the sample size par-
agraph, study power was considered in terms of both the
whole year group and the high-risk sub-group. The incor-
rect emphasis in the published study protocol paper on
the high risk sub-group analysis was a legacy of the fund-
ing proposal protocol, in which the sub-group sample size
calculations critically determined the number of schools
required for the trial.
Some other changes to the paragraph are also required to
contextualise the corrected status of the outcomes. The
corrected version of the paragraph should read:
Outcome measures and sample size calculations
The trial's primary outcome measure is smoking prev-
alence measured (i) among the high-risk group and
(ii) among the entire year group. The high-risk group
is defined as those students who, at baseline, had
experimented with cigarettes, were ex-smokers, or
were occasional (less than weekly) smokers. These stu-
dents are a primary target group because they are at
greatest risk of becoming regular smokers, and the fea-
sibility study showed an effect amongst this group
[18]. Smoking prevalence is defined as students smok-
ing a cigarette in the previous seven days. These out-
come measures are being validated by measurement of
salivary cotinine (a metabolite of nicotine), as studies
have found cotinine to be the most accurate biomar-
ker of smoke exposure in the previous two to three
days [22,23]. Secondary outcome measures include
perceptions of norms regarding adolescent smoking,
and intention to quit.
We apologise for any inconvenience caused in our over-
sight with regard to this important detail.
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